Karageorgos Ioannis, Gallagher Elyssia S, Galvin Connor, Gallagher D Travis, Hudgens Jeffrey W
Biomolecular Measurement Division, National Institute of Standards & Technology, Rockville, MD 20850, USA; Institute for Bioscience and Biotechnology Research, 9600 Gudelsky Drive, Rockville, MD 20850, USA.
Biomolecular Measurement Division, National Institute of Standards & Technology, Rockville, MD 20850, USA; Institute for Bioscience and Biotechnology Research, 9600 Gudelsky Drive, Rockville, MD 20850, USA.
Biologicals. 2017 Nov;50:27-34. doi: 10.1016/j.biologicals.2017.09.005. Epub 2017 Sep 29.
Monoclonal antibody pharmaceuticals are the fastest-growing class of therapeutics, with a wide range of clinical applications. To assure their safety, these protein drugs must demonstrate highly consistent purity and stability. Key to these objectives is higher order structure measurements validated by calibration to reference materials. We describe preparation, characterization, and crystal structure of the Fab fragment prepared from the NIST Reference Antibody RM 8671 (NISTmAb). NISTmAb is a humanized IgG1κ antibody, produced in murine cell culture and purified by standard biopharmaceutical production methods, developed at the National Institute of Standards and Technology (NIST) to serve as a reference material. The Fab fragment was derived from NISTmAb through papain cleavage followed by protein A based purification. The purified Fab fragment was characterized by SDS-PAGE, capillary gel electrophoresis, multi-angle light scattering, size exclusion chromatography, mass spectrometry, and x-ray crystallography. The crystal structure at 0.2 nm resolution includes four independent Fab molecules with complete light chains and heavy chains through Cys 223, enabling assessment of conformational variability and providing a well-characterized reference structure for research and engineering applications. This nonproprietary, publically available reference material of known higher-order structure can support metrology in biopharmaceutical applications, and it is a suitable platform for validation of molecular modeling studies.
单克隆抗体药物是增长最快的一类治疗药物,具有广泛的临床应用。为确保其安全性,这些蛋白质药物必须表现出高度一致的纯度和稳定性。实现这些目标的关键是通过与参考物质校准来验证的高阶结构测量。我们描述了从美国国家标准与技术研究院(NIST)参考抗体RM 8671(NISTmAb)制备的Fab片段的制备、表征和晶体结构。NISTmAb是一种人源化IgG1κ抗体,在鼠细胞培养物中产生,并通过标准生物制药生产方法纯化,由美国国家标准与技术研究院(NIST)开发用作参考物质。Fab片段是通过木瓜蛋白酶切割NISTmAb,然后基于蛋白A进行纯化得到的。纯化后的Fab片段通过SDS-PAGE、毛细管凝胶电泳、多角度光散射、尺寸排阻色谱、质谱和X射线晶体学进行表征。分辨率为0.2nm的晶体结构包括四个独立的Fab分子,其轻链和重链通过Cys 223完整,能够评估构象变异性,并为研究和工程应用提供一个特征明确的参考结构。这种具有已知高阶结构的非专利、公开可用的参考物质可支持生物制药应用中的计量学,并且是验证分子建模研究的合适平台。